Related Experiment Video
Updated: Jan 10, 2026

08:13
In-vitro Reconstitution of Bacterial Ubiquitination and VCP/p97-mediated Elimination
Published on: January 2, 2026
79
Ubiquitin Specific Peptidase 51 Exacerbates Skeletal Muscle Injury by Enhancing APAF1-Mediated Apoptosis and
1Department of Orthopedics, Shengli Clinical Medical College of Fujian Medical University, Fuzhou University Affiliated Provincial Hospital, Fuzhou, China.
Summary
Scientists found that USP51 deubiquitinating enzyme amplifies skeletal muscle injury (SMI) by stabilizing APAF1. Targeting the USP51-APAF1 axis may offer new treatments for muscle damage.
Area of Science:
- Biochemistry
- Cell Biology
- Molecular Medicine
Background:
- Skeletal muscle injury (SMI) involves complex cellular processes like oxidative stress, inflammation, and cell death.
- The precise molecular mechanisms controlling cell death pathways in SMI are not fully understood.
Purpose of the Study:
- To identify novel molecular regulators of cell death in skeletal muscle injury.
- To investigate the role of the deubiquitinating enzyme USP51 in SMI and its underlying mechanisms.
Main Methods:
- Utilized tBHP-induced oxidative stress in C2C12 myotubes and an AAV-mediated SMI mouse model.
- Performed functional assays, bioinformatic screening, protein-protein interaction analysis, co-immunoprecipitation, and ubiquitination assays.
- Assessed cell viability, apoptosis, pyroptosis, muscle damage, myofiber integrity, and inflammation.
Main Results:
- USP51 expression was upregulated in oxidative stress models.
- USP51 knockdown enhanced cell viability and suppressed apoptosis and pyroptosis.
- USP51 directly interacted with and deubiquitinated APAF1, increasing its stability.
- USP51 deficiency alleviated SMI in mice, an effect abolished by APAF1 overexpression.
Conclusions:
- USP51 acts as a novel positive regulator of SMI by stabilizing APAF1.
- The USP51-APAF1 axis plays a critical role in amplifying muscle damage.
- Targeting the USP51-APAF1 interaction presents a potential therapeutic strategy for SMI.
Related Concept Videos
The Unfolded Protein Response
6.2K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
6.2K
The Proteasome
1.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K
The Proteasome
10.0K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.0K
Regulation of the Unfolded Protein Response
2.9K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.9K
The Intrinsic Apoptotic Pathway
8.2K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.2K
Regulated Protein Degradation
8.7K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.7K

